120 related articles for article (PubMed ID: 12049957)
1. Comparing contrast-enhanced ultrasound to immunohistochemical markers of angiogenesis in a human melanoma xenograft model: preliminary results.
Forsberg F; Dicker AP; Thakur ML; Rawool NM; Liu JB; Shi WT; Nazarian LN
Ultrasound Med Biol; 2002 Apr; 28(4):445-51. PubMed ID: 12049957
[TBL] [Abstract][Full Text] [Related]
2. Monitoring angiogenesis in human melanoma xenograft model using contrast-enhanced ultrasound imaging.
Forsberg F; Ro RJ; Liu JB; Lipcan KJ; Potoczek M; Nazarian LN
Ultrason Imaging; 2008 Oct; 30(4):237-46. PubMed ID: 19507677
[TBL] [Abstract][Full Text] [Related]
3. Assessment of angiogenesis: implications for ultrasound imaging.
Forsberg F; Ro RJ; Potoczek M; Liu JB; Merritt CR; James KM; Dicker AP; Nazarian LN
Ultrasonics; 2004 Apr; 42(1-9):325-30. PubMed ID: 15047306
[TBL] [Abstract][Full Text] [Related]
4. Contrast enhanced maximum intensity projection ultrasound imaging for assessing angiogenesis in murine glioma and breast tumor models: A comparative study.
Forsberg F; Ro RJ; Fox TB; Liu JB; Chiou SY; Potoczek M; Goldberg BB
Ultrasonics; 2011 Apr; 51(3):382-9. PubMed ID: 21144542
[TBL] [Abstract][Full Text] [Related]
5. High and low frequency subharmonic imaging of angiogenesis in a murine breast cancer model.
Dahibawkar M; Forsberg MA; Gupta A; Jaffe S; Dulin K; Eisenbrey JR; Halldorsdottir VG; Forsberg AI; Dave JK; Marshall A; Machado P; Fox TB; Liu JB; Forsberg F
Ultrasonics; 2015 Sep; 62():50-5. PubMed ID: 25979676
[TBL] [Abstract][Full Text] [Related]
6. Correlation of ultrasound contrast agent derived blood flow parameters with immunohistochemical angiogenesis markers in murine xenograft tumor models.
Eisenbrey JR; Wilson CC; Ro RJ; Fox TB; Liu JB; Chiou SY; Forsberg F
Ultrasonics; 2013 Sep; 53(7):1384-91. PubMed ID: 23659876
[TBL] [Abstract][Full Text] [Related]
7. Comparing Quantitative Immunohistochemical Markers of Angiogenesis to Contrast-Enhanced Subharmonic Imaging.
Gupta A; Forsberg MA; Dulin K; Jaffe S; Dave JK; Halldorsdottir VG; Marshall A; Forsberg AI; Eisenbrey JR; Machado P; Fox TB; Liu JB; Forsberg F
J Ultrasound Med; 2016 Sep; 35(9):1839-47. PubMed ID: 27388814
[TBL] [Abstract][Full Text] [Related]
8. The antiangiogenic effects of a vascular endothelial growth factor decoy receptor can be monitored in vivo using contrast-enhanced ultrasound imaging.
Forsberg F; Ro RJ; Marshall A; Liu JB; Chiou SY; Merton DA; Machado P; Dicker AP; Nazarian LN
Mol Imaging; 2014; 13():1-9. PubMed ID: 24622811
[TBL] [Abstract][Full Text] [Related]
9. Vascularization of liver tumors - preliminary results with Coded Harmonic Angio (CHA), phase inversion imaging, 3D power Doppler and contrast medium-enhanced B-flow with second generation contrast agent (Optison).
Jung EM; Kubale R; Jungius KP; Jung W; Lenhart M; Clevert DA
Clin Hemorheol Microcirc; 2006; 34(4):483-97. PubMed ID: 16687788
[TBL] [Abstract][Full Text] [Related]
10. Dose-response relationship of ultrasound contrast agent in an in vivo murine melanoma model.
Seiler GS; Ziemer LS; Schultz S; Lee WM; Sehgal CM
Cancer Imaging; 2007 Dec; 7(1):216-23. PubMed ID: 18083651
[TBL] [Abstract][Full Text] [Related]
11. The antivascular action of physiotherapy ultrasound on murine tumors.
Wood AK; Ansaloni S; Ziemer LS; Lee WM; Feldman MD; Sehgal CM
Ultrasound Med Biol; 2005 Oct; 31(10):1403-10. PubMed ID: 16223644
[TBL] [Abstract][Full Text] [Related]
12. Histopathological observations of the antivascular effects of physiotherapy ultrasound on a murine neoplasm.
Bunte RM; Ansaloni S; Sehgal CM; Lee WM; Wood AK
Ultrasound Med Biol; 2006 Mar; 32(3):453-61. PubMed ID: 16530105
[TBL] [Abstract][Full Text] [Related]
13. Angiogenesis model for ultrasound contrast research: exploratory study.
Lucidarme O; Nguyen T; Kono Y; Corbeil J; Choi SH; Varner J; Mattrey RF
Acad Radiol; 2004 Jan; 11(1):4-12. PubMed ID: 14746396
[TBL] [Abstract][Full Text] [Related]
14. The antivascular action of physiotherapy ultrasound on a murine tumor: role of a microbubble contrast agent.
Wood AK; Bunte RM; Cohen JD; Tsai JH; Lee WM; Sehgal CM
Ultrasound Med Biol; 2007 Dec; 33(12):1901-10. PubMed ID: 17720299
[TBL] [Abstract][Full Text] [Related]
15. Angiogenesis inhibitors in a murine neuroblastoma model: quantitative assessment of intratumoral blood flow with contrast-enhanced gray-scale US.
McCarville MB; Streck CJ; Dickson PV; Li CS; Nathwani AC; Davidoff AM
Radiology; 2006 Jul; 240(1):73-81. PubMed ID: 16793972
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of tumor angiogenesis in a mouse PC-3 prostate cancer model using dynamic contrast-enhanced sonography.
Lee HJ; Hwang SI; Chung JH; Jeon JJ; Choi JH; Jung HS
J Ultrasound Med; 2012 Aug; 31(8):1223-31. PubMed ID: 22837286
[TBL] [Abstract][Full Text] [Related]
17. Correlation of quantified contrast-enhanced sonography with in vivo tumor response.
Hwang M; Hariri G; Lyshchik A; Hallahan DE; Fleischer AC
J Ultrasound Med; 2010 Apr; 29(4):597-607. PubMed ID: 20375378
[TBL] [Abstract][Full Text] [Related]
18. Effects of low-frequency ultrasound and microbubbles on angiogenesis-associated proteins in subcutaneous tumors of nude mice.
Shen ZY; Shen E; Zhang JZ; Bai WK; Wang Y; Yang SL; Nan SL; Lin YD; Li Y; Hu B
Oncol Rep; 2013 Aug; 30(2):842-50. PubMed ID: 23707983
[TBL] [Abstract][Full Text] [Related]
19. Combination of a selective cyclooxygenase-2 inhibitor with epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 and protein kinase A antisense causes cooperative antitumor and antiangiogenic effect.
Tortora G; Caputo R; Damiano V; Melisi D; Bianco R; Fontanini G; Veneziani BM; De Placido S; Bianco AR; Ciardiello F
Clin Cancer Res; 2003 Apr; 9(4):1566-72. PubMed ID: 12684433
[TBL] [Abstract][Full Text] [Related]
20. Microultrasound molecular imaging of vascular endothelial growth factor receptor 2 in a mouse model of tumor angiogenesis.
Rychak JJ; Graba J; Cheung AM; Mystry BS; Lindner JR; Kerbel RS; Foster FS
Mol Imaging; 2007; 6(5):289-96. PubMed ID: 18092513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
